HealthStream Reports Strong Q1 Financials, Continues Share Repurchases, and Updates Capital Allocation

summarizeSummary

HealthStream reported robust Q1 2026 financial results, including double-digit revenue and profit growth, alongside continued execution of its share repurchase programs and a declared quarterly dividend.

check_boxKey Events

• Strong Q1 Financial Performance

  Reported Q1 2026 revenue of $81.2 million, up 10.5% year-over-year, with net income increasing 36.4% to $5.9 million and diluted EPS reaching $0.20, up from $0.14 in Q1 2025. Adjusted EBITDA grew 24.1% to $20.1 million.

• Active Share Repurchase Programs

  Completed a $10.0 million share repurchase program in January 2026, buying back $5.0 million in Q1. A new $10.0 million program was initiated on March 13, 2026, under which $2.5 million was repurchased by March 31, 2026, and an additional $1.8 million through April 30, 2026, leaving $5.7 million remaining.

• Quarterly Dividend Declared

  The Board declared a quarterly cash dividend of $0.035 per share on May 4, 2026, payable on May 29, 2026, to shareholders of record on May 18, 2026. This follows a previous dividend of $0.035 per share paid on March 20, 2026.

• Revolving Credit Facility Update

  A First Amendment to the revolving credit facility was executed on March 13, 2026, revising restricted payments provisions. The facility provides up to $50.0 million, plus a $25.0 million accordion feature, with no outstanding balances and the company in compliance with all covenants.

auto_awesomeAnalysis

HealthStream's Q1 2026 10-Q filing confirms the strong financial performance previously announced, with significant year-over-year growth in revenue, net income, and EPS. The company continues its active capital return strategy, completing one share repurchase program and making substantial progress on a new $10.0 million authorization. While the core earnings figures were pre-released via an 8-K, this 10-Q provides comprehensive financial statements and additional details on capital allocation, including post-quarter-end share repurchases. The amendment to the revolving credit facility, while broadening restrictions on capital returns, does not immediately impact the company's strong liquidity position or its ability to execute current programs. A director's newly disclosed 10b5-1 plan for a modest number of shares is noted, though no sales have occurred.